Benjamin J. Zeskind insider trades

Open-market stock purchases and sales by Benjamin J. Zeskind, PRESIDENT AND CEO at Immuneering Corp, from SEC Form 4 filings since Aug 3, 2021.

Track record: 57% of 7 scored buys are up 5% or more since purchase, averaging +5%.

Recent trades

DateStockTradeValue
Jun 23, 2026IMRX Immuneering CorpBought$10.9K
Feb 3, 2026IMRX Immuneering CorpBought (not open market)—

Companies traded

  • IMRX Immuneering Corp: 8 buys, last Jun 23, 2026

Get free alerts when Benjamin J. Zeskind files a new trade →